Insmed Inc Stock Performance
| INSM Stock | USD 24.32 0.48 1.94% |
The company retains a Market Volatility (i.e., Beta) of 1.7, which attests to a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Insmed will likely underperform. Insmed Inc has an expected return of -0.22%. Please make sure to check out Insmed total risk alpha, kurtosis, as well as the relationship between the Kurtosis and day typical price , to decide if Insmed Inc performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days Insmed Inc has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unsteady performance in the last few months, the Stock's basic indicators remain very healthy which may send shares a bit higher in May 2024. The recent disarray may also be a sign of long period up-swing for the firm investors. ...more
Actual Historical Performance (%)
One Day Return (5.27) | Five Day Return (12.65) | Year To Date Return (17.17) | Ten Year Return 71.63 | All Time Return (84.97) |
Last Split Factor 1:10 | Last Split Date 2011-03-03 |
1 | E Fund Management Co. Ltd. Sells 5,905 Shares of Insmed Incorporated | 02/16/2024 |
2 | UBS initiates Insmed coverage with buy, sets 46 stock target | 02/26/2024 |
3 | Acquisition by Melvin Sharoky of 1200 shares of Insmed subject to Rule 16b-3 | 02/28/2024 |
4 | FY2024 EPS Estimates for Insmed Incorporated Lowered by Cantor Fitzgerald - AmericanBankingNEWS | 03/01/2024 |
5 | Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635 | 03/05/2024 |
6 | California State Teachers Retirement System Cuts Position in Insmed Incorporated - Defense World | 03/11/2024 |
7 | Graham Capital Management L.P. Purchases 33969 Shares of Insmed Incorporated - Defense World | 03/14/2024 |
8 | Acquisition by Michael Smith of 58260 shares of Insmed at 29.13 subject to Rule 16b-3 | 04/02/2024 |
9 | Arizona State Retirement System Sells 657 Shares of Insmed Incorporated - Defense World | 04/16/2024 |
| Begin Period Cash Flow | 1.1 B |
Insmed |
Insmed Relative Risk vs. Return Landscape
If you would invest 2,853 in Insmed Inc on January 20, 2024 and sell it today you would lose (421.00) from holding Insmed Inc or give up 14.76% of portfolio value over 90 days. Insmed Inc is currently does not generate positive expected returns and assumes 2.4131% risk (volatility on return distribution) over the 90 days horizon. In different words, 21% of stocks are less volatile than Insmed, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Insmed Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Insmed's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Insmed Inc, and traders can use it to determine the average amount a Insmed's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.093
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | INSM |
Estimated Market Risk
| 2.41 actual daily | 21 79% of assets are more volatile |
Expected Return
| -0.22 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.09 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Insmed is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Insmed by adding Insmed to a well-diversified portfolio.
Insmed Fundamentals Growth
Insmed Stock prices reflect investors' perceptions of the future prospects and financial health of Insmed, and Insmed fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Insmed Stock performance.
| Return On Equity | -14.53 | ||||
| Return On Asset | -0.28 | ||||
| Profit Margin | (2.46) % | ||||
| Operating Margin | (1.94) % | ||||
| Current Valuation | 4.26 B | ||||
| Shares Outstanding | 148.56 M | ||||
| Price To Earning | (8.70) X | ||||
| Price To Book | 25.45 X | ||||
| Price To Sales | 13.26 X | ||||
| Revenue | 305.21 M | ||||
| Gross Profit | 190.23 M | ||||
| EBITDA | (673.93 M) | ||||
| Net Income | (749.57 M) | ||||
| Cash And Equivalents | 554.87 M | ||||
| Cash Per Share | 4.62 X | ||||
| Total Debt | 1.2 B | ||||
| Current Ratio | 5.93 X | ||||
| Book Value Per Share | (2.24) X | ||||
| Cash Flow From Operations | (536.25 M) | ||||
| Earnings Per Share | (5.34) X | ||||
| Market Capitalization | 3.68 B | ||||
| Total Asset | 1.33 B | ||||
| Retained Earnings | (3.45 B) | ||||
| Working Capital | 703.43 M | ||||
| Current Asset | 28.15 M | ||||
| Current Liabilities | 3.89 M | ||||
About Insmed Performance
To evaluate Insmed Inc Stock as a possible investment, you need to clearly understand its upside potential, downside risk, and overall future performance outlook. You may be satisfied when Insmed generates a 15% return over the last few months, but what if the market is generating 25% over the same period? In this case, it makes sense to compare Insmed Stock's performance with different market indexes, such as the Dow or NASDAQ Composite. These indexes can act as benchmarks that will help you to understand Insmed Inc market performance in a much more refined way. The Macroaxis performance score is an integer between 0 and 100 that represents Insmed's market performance from a risk-adjusted return perspective. Generally speaking, the higher the score, the better is overall performance as compared to other investors. The score is normalized against the average investing universe (the best we can interpret from the data available). Within this methodology, scores of individual equity instruments will always be inferior to the scores of portfolios of equities as portfolios typically diversify a lot of unsystematic risks away. The formula to derive the Macroaxis score bases on multiple unequally-weighted factors. For more information, refer to our portfolio performance evaluation section.
Please also refer to our technical analysis and fundamental analysis pages.| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | 463.38 | 559.67 | |
| Return On Tangible Assets | (0.66) | (0.70) | |
| Return On Capital Employed | (0.64) | (0.61) | |
| Return On Assets | (0.56) | (0.59) | |
| Return On Equity | 2.26 | 2.37 |
Things to note about Insmed Inc performance evaluation
Checking the ongoing alerts about Insmed for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Insmed Inc help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Insmed Inc generated a negative expected return over the last 90 days | |
| Insmed Inc has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the previous year's revenue of 305.21 M. Net Loss for the year was (749.57 M) with profit before overhead, payroll, taxes, and interest of 190.23 M. | |
| Insmed Inc currently holds about 554.87 M in cash with (536.25 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 4.62. | |
| Insmed Inc has a very weak financial position based on the latest SEC disclosures | |
| Over 99.0% of the company shares are owned by institutional investors | |
| Latest headline from news.google.com: Arizona State Retirement System Sells 657 Shares of Insmed Incorporated - Defense World |
- Analyzing Insmed's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Insmed's stock is overvalued or undervalued compared to its peers.
- Examining Insmed's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Insmed's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Insmed's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Insmed's stock. These opinions can provide insight into Insmed's potential for growth and whether the stock is currently undervalued or overvalued.
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Insmed Inc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in state. You can also try the Money Managers module to screen money managers from public funds and ETFs managed around the world.
Complementary Tools for Insmed Stock analysis
When running Insmed's price analysis, check to measure Insmed's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Insmed is operating at the current time. Most of Insmed's value examination focuses on studying past and present price action to predict the probability of Insmed's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Insmed's price. Additionally, you may evaluate how the addition of Insmed to your portfolios can decrease your overall portfolio volatility.
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance |
Is Insmed's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Insmed. If investors know Insmed will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Insmed listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (5.34) | Revenue Per Share 2.173 | Quarterly Revenue Growth 0.411 | Return On Assets (0.28) | Return On Equity (14.53) |
The market value of Insmed Inc is measured differently than its book value, which is the value of Insmed that is recorded on the company's balance sheet. Investors also form their own opinion of Insmed's value that differs from its market value or its book value, called intrinsic value, which is Insmed's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Insmed's market value can be influenced by many factors that don't directly affect Insmed's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Insmed's value and its price as these two are different measures arrived at by different means. Investors typically determine if Insmed is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Insmed's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.